Cellectar Biosciences, Inc. CLRB
NASDAQ · United States · Health Technology
$1.83-0.03 (-1.72%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-13 | -0.57 | -0.52 | -9.6% | $0 | — | 0.0%$2.60→$2.60 |
| Q1 2026 | 2026-05-14 | -1.33 | -1.35 | +1.5% | — | — | +5.1%$2.94→$3.09 |
| Q4 2025 | 2026-03-04 | -0.53 | -1.23 | +56.9% | — | — | +3.4%$2.68→$2.77 |
| Q3 2025 | 2025-11-13 | -1.41 | -2.53 | +44.3% | — | — | -17.1%$3.50→$2.90 |
| Q2 2025 | 2025-08-14 | -3.39 | -3.70 | +8.4% | — | — | — |
| Q1 2025 | 2025-05-13 | -4.20 | -4.90 | +14.3% | — | — | — |
| Q4 2024 | 2025-03-13 | -0.30 | -10.58 | +97.2% | — | — | — |
| Q3 2024 | 2024-11-18 | -11.10 | -11.20 | +0.9% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.